Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: Am J Infect Control. 2018 Nov 22;47(3):334–336. doi: 10.1016/j.ajic.2018.09.004

Table 1.

Characteristics of patients in the intervention and control groups

Characteristic Intervention group
(n = 42)
Control group
(n = 40)
P value

Male sex, n (%) 41 (98) 37 (93) .35
Age, y, median 64 63 .65
Long-term care facility resident, 7(17) 8 (20) .78
 n (%)
Medical condition, n (%)
 Diabetes 19 (45) 14(35) .06
 Cancer 10(24) 6(15) .41
 Chronic lung disease 12(29) 11 (28) 1.0
 Surgery in the past 3 mo 13(31) 8 (20) .32
Colonized on admission, n (%)
 MRSA 0(0) 1 (2) .49
 VRE 7(17) 4(10) .52
 Fluoroquinolone-resistant 6 (14) 5(13) 1.0
 gram-negative bacilli
Candida spp 410) 6(15) .51
Proton pump inhibitor, n (%) 26 (62) 25 (51) 1.0
Antibiotics within 90 d, n (%) 22 (52) 19(48) .83

MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci.